PHARMASUST 300 - Pharmacom Labs

Originally created by Organon ( Merck/MSD) in the 1970s, for enhanced convenience compared to single ester testosterone products that necessitate more frequent injections. In the USA Sustanon has not been approved far, because of the high costs associated with FDA approval and the availability of similar options, on the market. When it comes specifically for cutting or dieting phases in bodybuilding routines Sustanon is generally not recommended due its tendency at doses causing water retention and potentially impacting muscle definition negatively. However its mild estrogenic characteristics do render it appropriate, for bulking periods when retaining water can be advantageous, in fostering strength improvements and muscle development. Globally, Sustanon continues its reign as one of the sought after testosterone products available today.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about PHARMASUST 300 by Pharmacom Labs, consult with your doctor or healthcare professional.